Research location
Hengelo
Netherlands
Advertisement
Research activity in Hengelo
NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 76 trials and 76 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hengelo
76 linked trials · page 1 of 2Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast CancerNCT07146295 · 2025-04-18 · 1 site observation
RECRUITING
OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating LymphocytesNCT06476119 · 2025-04-15 · 1 site observation
RECRUITING
Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate CancerNCT07260435 · 2024-02-20 · 1 site observation
RECRUITING
External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery Evaluation in Breast Reconstructive SurgeryNCT05003635 · 2021-07-12 · 1 site observation
RECRUITING
AFT: Introduction of a Full Breast Reconstructive MethodNCT04261829 · 2020-12-09 · 1 site observation
RECRUITING
Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast CancerNCT04486495 · 2020-07-16 · 1 site observation
RECRUITING
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerNCT05514054 · 2022-10-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Lung EpiCheck Biomarkers Development StudyNCT06245876 · 2022-05-17 · 1 site observation
COMPLETED
REsponsible roLl-out of E-heAlth Through Systematic Evaluation - Heart Failure StudyNCT05654961 · 2022-01-01 · 1 site observation
UNKNOWN
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF StudyNCT04754087 · 2021-07-07 · 1 site observation
ACTIVE_NOT_RECRUITING
CONFIDENCE RegistryNCT05084729 · 2020-09-11 · 1 site observation
COMPLETED
Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast CancerNCT04494425 · 2020-07-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation TherapyNCT03703297 · 2018-09-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT03478683 · 2018-06-25 · 1 site observation
COMPLETED
INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice DesignNCT03467425 · 2018-04-11 · 1 site observation
COMPLETED
A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic SubjectsNCT03380429 · 2018-01-31 · 1 site observation
COMPLETED
Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIsNCT03114969 · 2017-06-08 · 1 site observation
COMPLETED
Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With DocetaxelNCT03295565 · 2017-05-07 · 1 site observation
COMPLETED
Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT03034967 · 2017-04-25 · 1 site observation
COMPLETED
RISAS Procedure in Node Positive Breast Cancer Following NACNCT02800317 · 2017-03-30 · 1 site observation
COMPLETED
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)NCT03043872 · 2017-03-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Management of Low-risk (Grade I and II) DCISNCT02492607 · 2017-02-13 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled AsthmaNCT02924688 · 2016-10-13 · 1 site observation
COMPLETED
LUME BioNIS: a Biomarker Study in Patients With NSCLCNCT02671422 · 2016-03-09 · 1 site observation
COMPLETED
Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With AsthmaNCT02571777 · 2015-12-08 · 1 site observation
COMPLETED
Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard TherapyNCT02339779 · 2015-10-01 · 1 site observation
ACTIVE_NOT_RECRUITING
IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO)NCT02364388 · 2015-03-27 · 1 site observation
COMPLETED
Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside TamoxifenNCT02285179 · 2014-11-01 · 1 site observation
COMPLETED
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 1 site observation
COMPLETED
A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC ParticipantsNCT02040935 · 2014-02-21 · 1 site observation
COMPLETED
Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).NCT01957150 · 2014-01-28 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentNCT01702571 · 2012-11-27 · 1 site observation
COMPLETED
Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01529632 · 2012-05-01 · 1 site observation
COMPLETED
Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary DiseaseNCT01559116 · 2012-03-01 · 1 site observation
COMPLETED
Systemic Therapy With or Without Upfront Surgery in Metastatic Breast CancerNCT01392586 · 2012-02-01 · 1 site observation
TERMINATED
Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE TrialNCT01315015 · 2011-11-01 · 1 site observation
COMPLETED
Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)NCT01431274 · 2011-09-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesNCT01076647 · 2010-03-01 · 1 site observation
COMPLETED
Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)NCT01103089 · 2010-03-01 · 1 site observation
COMPLETED
Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD)NCT01040403 · 2010-01-01 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection FractionNCT00887588 · 2009-11-01 · 1 site observation
COMPLETED
Study to Assess the Effects of High Protein Diet in Obesity, the LOWER StudyNCT00862953 · 2008-07-01 · 1 site observation
COMPLETED
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusNCT00700817 · 2008-06-01 · 1 site observation
COMPLETED
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.NCT00603746 · 2007-12-01 · 1 site observation
COMPLETED
ARTS - AVODART After Radical Therapy For Prostate Cancer StudyNCT00558363 · 2007-11-01 · 1 site observation
COMPLETED
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate AlzheimersNCT00490568 · 2007-08-08 · 1 site observation
TERMINATED
Reduction of Falls in the Elderly - Parkinson's DiseaseNCT00518648 · 2007-08-01 · 1 site observation
COMPLETED
Integrated Multidisciplinary Care for Parkinson's Disease: a Controlled TrialNCT00518791 · 2007-08-01 · 1 site observation
COMPLETED
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeNCT00505388 · 2007-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.